Medtronic PLC (NYSE:MDT) was influenced by a mix of regulatory alerts, clinical progress, analyst revisions and corporate updates that investors will want to consider.
Positive Sentiment:
Citigroup raised its price target on MDT shares to $99.00 and maintained a "buy" rating, suggesting more upside potential.
Medtronic (NYSE:MDT) Given New $99.00 Price Target at Citigroup
Positive Sentiment:
An investment roundup names Medtronic a “no-brainer” dividend stock to buy and hold forever, highlighting its reliable payout track record.
1 No-Brainer Dividend Stock to Buy Now and Hold Forever
Positive Sentiment:
Medtronic treated the first patient in its multi-organ denervation study for hypertension, marking a key clinical milestone for its high-blood-pressure device program.
Medtronic treats first patient in multi-organ denervation study for high blood pressure
Positive Sentiment:
Medtronic appointed a CFO for its planned diabetes spinoff, strengthening leadership ahead of the separation.
Medtronic names CFO for diabetes spinoff
Neutral Sentiment:
The company highlighted how its healthcare technology supports wildlife conservation, a corporate-social-responsibility win with limited direct financial impact.
Medtronic PLC (MDT) Advances Wildlife Conservation with Healthcare Technology
Neutral Sentiment:
An update from the Mid-Q Response Study offers additional data on Medtronic’s cardiac care research, with no groundbreaking results announced.
Medtronic’s Mid-Q Response Study: A New Chapter in Cardiac Care
Neutral Sentiment:
Needham kept a hold rating on MDT amid the diabetes spin-off process, reflecting a cautious stance.
Needham Keeps Hold Rating on Medtronic (MDT) Amid Spin-Off News
Neutral Sentiment:
An overview piece notes MDT’s gains in a down market but cites no specific new catalyst.
Medtronic (MDT) Gains As Market Dips: What You Should Know
Negative Sentiment:
The FDA issued an early alert for Medtronic’s pH monitoring capsules over potential safety or labeling concerns, raising the prospect of future regulatory action.
FDA Issues Early Alert for Medtronic pH Monitoring Capsules
Posted 4h ago
AI Generated. May Contain Errors.